This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Cell & Gene Therapy

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Events

Showing 5 of 8 eventsView all events
Featured

Cell Therapy Manufacturing & Gene Therapy Congress

1 - 4 December 2020, Amsterdam

Join a handpicked lineup of the brightest minds in cell and gene therapy

Go to site

Cell Therapy Manufacturing Asia

27-28 February 2020, Kyoto, Japan

The ONLY Cell and Gene Therapy event in Asia to help you fast track manufacturing & commercialization across borders

Applications of Gene Editing

June 22-24, 2020, San Francisco, CA

Precise, efficient & safer genome editing – changing the face of genetic disorders and rare disease

Next Generation CAR & T Cell Therapies

June 22-24, 2020, San Francisco, CA

CAR and T Cell Therapies: Pioneering point of care with innovative manufacturing and commercialization strategies

Next Generation Protein Therapeutics Summit

June 22-24, 2020, San Francisco, CA

Looking beyond antibodies to transform promising proteins into next generation medicine

Articles & Video

Showing 9 of 63 articles & videoView all articles & video
Featured
Antibody Engineering

Life Sciences in 2020: Predictions from industry insiders

Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.

Premium
Cell and gene therapy

REPORT: Cell and Gene Therapy Analytics, Manufacturing and Supply Chain

Explore and download our latest data report on Cell and Gene Therapy Analytics, Manufacturing and Supply Chain, in partnership with Intertek.

Premiumget_app
Outsourcing

Insourcing vs outsourcing in cell and gene therapy manufacturing - WHITEPAPER

This whitepaper presents best practices for planning an outsourcing or insourcing strategy for manufacturing cell and gene therapies.

Biotech Showcase™ 2020

PharmAI – Industry is Smartening Up to Potential of Artificial Intelligence

Artificial Intelligence (AI) has enormous potential in changing the delivery of health care and improving patient outcomes, with applications in pattern detection, patient monitoring, disease diagnosis and treatment selection. The rationale is that AI can be used to enhance the decision-making process, taking into account far more data than are available to physicians via conventional means.

Cost

Evolving cost-effectiveness assessment as gene therapy care evolves

Cell and gene therapy

What is cell therapy?

Brazil

The challenge - and opportunity - of gene therapies in emerging markets

Cell and gene therapy

Mesenchymal stem cells and understanding drug development processes

CAR-T

What can reduce the cost of CAR-T therapy? - INDUSTRY VOICES

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 31,000+ cell therapy executives and scientists, including 1,800+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Luke Pickering, Account Director:
luke.pickering@informa.com | +44.(0)20.3377.3553

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2020 Informa Connect, a trading name of IIR Limited. IIR Limited registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.